Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...
Hydro’s adjusted EBITDA for the fourth quarter of 2024 was NOK 7,701 million, up from NOK 3,737 million in the same quarter last year. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback